Pharmacokinetics of Propofol in Morbidly Obese Patients
Status:
Completed
Trial end date:
2014-05-07
Target enrollment:
Participant gender:
Summary
The objectives of this study are
- To determine PK of propofol in bariatric patients
- To identify the physiological variables that induce propofol PK changes in bariatric
patients, when compared to a normal-weight population.
- To define context-sensitive half-time profiles for propofol in bariatric patients.